Bliss GVS Pharma Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

Particulars	Mar-25	Jun-25	Sep-25	Dec-25	Mar-26
Revenue	198	207	244	218	257
Other income	12	36	20	19	11
Expenses	187	180	224	193	223
Cost of materials consumed	77	93	95	86	111
Purchases of stock-in-trade	14	21	2	20	18
Change in inventories	9	-22	20	-5	-16
Employee benefit expense	28	31	33	36	36
Finance costs	2	6	3	2	2
Depreciation & amortisation	8	8	8	8	9
Other expenses	49	43	61	46	63
EBITDA	33	77	52	51	56
EBIT	25	69	44	42	47
Exceptional items	-	-	-	-3	-
Profit Before Tax	23	63	41	41	45
Tax expense	7	19	12	16	8
Deferred tax	0.90	-2	-2	2	-12
Net Profit	17	44	29	25	37
Financial Ratios
Operating Profit Margin	12.68%	33.14%	17.87%	19.45%	18.29%
EBITDA Margin	16.72%	37.10%	21.27%	23.26%	21.67%
Net Profit Margin	8.38%	21.45%	11.72%	11.38%	14.40%
Earnings Per Share (₹)	1.47	4.08	2.58	2.20	3.37

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.